A Phase 2a, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of AT-1501 in Patients with IgA Nephropathy

  • Ryan, Jessica (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date5/04/22 → 4/04/27

Keywords

  • multicentre trial
  • phase 2 study
  • nephropathy
  • treatment safety
  • treatment efficacy